61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Accuray Inc
Closed
Sector Healthcare
2.01 5.24
Overview
Share price change
24h
Min
1.88
Max
2.01
Income | -4M |
|---|---|
Sales | -5.7M 102M |
EPS | -0.04 |
Profit margin | -3.894 |
Recommendations | Buy |
|---|---|
12 Months Forecast | +240.31 upside |
Next Earnings | 29 Jan 2025 |
|---|
Market Cap | 1M 239M |
|---|---|
Previous open | -3.23 |
Previous close | 2.01 |
News Sentiment
By Acuity
22%
78%
57 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Accuray Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Accuray Inc Forecast
Price Target
By TipRanks
240.31% upside
12 Months Forecast
Average 6.5 USD 240.31%
High 7 USD
Low 6 USD
Based on 2 Wall Street analysts offering 12 month price targets forAccuray Inc - Dist in the last 3 months.
Sentiment
By Acuity
57 / 392 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Accuray Inc
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.
